These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma. Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330 [TBL] [Abstract][Full Text] [Related]
7. Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients? Van Gool S; De Vleeschouwer S Expert Rev Neurother; 2012 Oct; 12(10):1173-6. PubMed ID: 23082731 [No Abstract] [Full Text] [Related]
8. Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope? Ferguson SD; Srinivasan VM; Ghali MG; Heimberger AB Immunotherapy; 2016; 8(4):413-23. PubMed ID: 26973123 [TBL] [Abstract][Full Text] [Related]
9. First results on the DCVax phase III trial: raising more questions than providing answers. Wick W; van den Bent MJ Neuro Oncol; 2018 Sep; 20(10):1283-1284. PubMed ID: 30137551 [No Abstract] [Full Text] [Related]
10. Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme. Jan CI; Tsai WC; Harn HJ; Shyu WC; Liu MC; Lu HM; Chiu SC; Cho DY Front Immunol; 2018; 9():727. PubMed ID: 29910795 [TBL] [Abstract][Full Text] [Related]
11. [II. Autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma]. Maruyama T; Muragaki Y; Ishikawa E; Nitta M; Saito T; Ohno T; Iseki H; Okada Y Gan To Kagaku Ryoho; 2015 Jun; 42(6):683-6. PubMed ID: 26242005 [No Abstract] [Full Text] [Related]
12. Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme. De Vleeschouwer S; Fieuws S; Rutkowski S; Van Calenbergh F; Van Loon J; Goffin J; Sciot R; Wilms G; Demaerel P; Warmuth-Metz M; Soerensen N; Wolff JE; Wagner S; Kaempgen E; Van Gool SW Clin Cancer Res; 2008 May; 14(10):3098-104. PubMed ID: 18483377 [TBL] [Abstract][Full Text] [Related]
19. The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer. Luo XH; Meng Q; Rao M; Liu Z; Paraschoudi G; Dodoo E; Maeurer M Immunology; 2018 Nov; 155(3):294-308. PubMed ID: 30098205 [TBL] [Abstract][Full Text] [Related]
20. Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma. Curry WT; Gorrepati R; Piesche M; Sasada T; Agarwalla P; Jones PS; Gerstner ER; Golby AJ; Batchelor TT; Wen PY; Mihm MC; Dranoff G Clin Cancer Res; 2016 Jun; 22(12):2885-96. PubMed ID: 26873960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]